Skip to main content
SpringerLink
Log in

Pancreatic Islet and Stem Cell Transplantation in Diabetes Mellitus: Results and Perspectives

  • Chapter
Tissue Engineering, Stem Cells, and Gene Therapies

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 534))

Abstract

Long-term studies strongly suggest that tight control of blood glucose achieved by conventional intensive insulin treatment, self-blood glucose monitoring and patient education can significantly prevent the development and retard the progression of chronic complications of type 1 diabetes mellitus. However, the expense for this benefit was a threefold increase of the number of severe hypoglycemic episodes, a significant increase of the body weight, and dietary and other life-style restrictions affecting the quality of life

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. The Diabetes Control and Complications Trial Research Group, 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.N. Engl. J. Med. 329977–986.

    Article  Google Scholar 

  2. Wang, P.H., Lau, J., and Chalmers, T.C., 1993, Meta-analysis of effects of intensive blood-glucose control on late complications of type-1 diabetes.Lancet 3411306–1309.

    Article  Google Scholar 

  3. The Diabetes Control and Complications Trial Research Group, 1997, Hypoglycemia in the Diabetes Control and Complications Trial.Diabetes 46271–286

    Article  Google Scholar 

  4. Sutherland, D.E., Gores, P.F., Farney, A.C., Wahoff, D.C., Matas, A.J., Dunn, D.L., Gruessner, R.W., and Najarian, J.S., 1993, Evolution of kidney, pancreas, and islet transplantation for patients with diabetes at the University of Minnesota.Am. J. Surg. 166456–491.

    Article  Google Scholar 

  5. Bretzel, R.G., Browatzki, C.C, Schultz, A., Brandhorst, H., Kutscher, D., Bollen, C.C., Raptis, G., Friemann, S., Ernst, W., Rau, W.S., and Hering, B.J., 1993, Clinical islet transplantation in diabetes mellitus - report of the Islet Transplant Registry and the Giessen Center experience.Diab. Stoff v. 2378–390.

    Google Scholar 

  6. Gruessner, R.W.G., Sutherland, D.E.R., Troppmann, C., Benedetti, E., Hakim, N., Dunn, D.L., and Gruessner, A.C., 1997, The surgical risk of pancreas transplantation in the cyclosporine era: an overview:J. Am. Coll. Surg. 185128–144.

    Article  Google Scholar 

  7. Manske, C.L., 1999, Risks and benefits of kidney and pancreas transplantation for diabetic patients.Diabetes Care 22, B114–B120.

    Google Scholar 

  8. Humar, A., Kandaswamy, R., Granger, D. et al., 2000, Decreased surgical risks of pancreas transplantation in the modern era.Ann. Surg. 231342–344.

    Article  Google Scholar 

  9. Weimar, B., Rauber, K., Brendel, M.D., Bretzel, R.G., and Rau, W.S., 1999, Percutaneous transhepatic catheterization of the portal vein: a combined CT- and fluoroscopy-guided technique. Cardiovasc.Intervent. Radiol. 22342–344.

    Article  Google Scholar 

  10. Scharp, D.W., Lacy, P.E., Santiago, J.V., McCullough, C.S., Weide, L.G., Falqui, L. et al., 1990, Insulin independence after islet transplantation into type I diabetic patient.Diabetes 39515–518.

    Article  Google Scholar 

  11. Socci, C., Falqui, L., Davalli, A.M., Ricordi, C., Braghi, S., Bertuzzi, F. et al., 1991, Fresh human islet transplantation to replace pancreatic endocrine function in type 1 diabetic patients. Report of six cases.Acta Diabetol. 28151–157.

    Article  Google Scholar 

  12. Warnock, G.L., Kneteman, N.M., Ryan, E.A., Rabinovitch, A., and Rajotte, R.V., 1992, Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with Type 1 (insulin-dependent) diabetes mellitus.Diabetologia 3589–95.

    Article  Google Scholar 

  13. Gores, P.F., Najarian, J.S., Stephanian, E., Lloveras, J.J., Kelley, S.L., and Sutherland, D.E.R., 1993, Insulin independence in type I diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin.Lancet 34119–21.

    Article  Google Scholar 

  14. Alejandro, R., Lehmann, R., Ricordi, C., Kenyon, N.S., Angelico, M.C., Burke, G. et al., 1997, Long-term function (6 years) of islet allografts in type 1 diabetes.Diabetes 461983–1989.

    Article  Google Scholar 

  15. Brendel, M.D., Hering, B.J., Schultz, A.O., and Bretzel, R.G., 2001, International Islet Transplant Registry Newsletter No.9:1–20.

    Google Scholar 

  16. Bretzel, R.G., 1999, Biological alternatives to insulin therapy.Exp. Clin. Endocrinol. Diabetes 107S39–S43.

    Article  Google Scholar 

  17. Mering, J. von, and Minkowski, O., 1890, Diabetes mellitus nach Pankreasexstirpation.Arch. Exp. Pathol. Pharmakol. 2637.

    Google Scholar 

  18. Minkowski, O., 1892, Weitere Mittheilungen über den Diabetes mellitus nach Exstirpation des Pankreas.Berliner Klin. Wochenschr. 2990–94.

    Google Scholar 

  19. Banting, F.G., and Best, C.H., 1922, The internal secretion of the pancreas.J. Lab. Clin. Invest. 7251–266.

    Google Scholar 

  20. Williams, P.W., 1894, Notes on diabetes treated with extract and by grafts of sheep’s pancreas.Brit. Med. J. 21303.

    Google Scholar 

  21. Ricordi, C., Lacy, P.E., Finke, E.H., Olack, B.J., and Scharp, D.W., 1988, Automated method for isolation of human pancreatic islets.Diabetes 37413–420.

    Article  Google Scholar 

  22. Johansson, B.L., Borg, K., Femgvist-Forbes, E., Odergren, T., Remahl, S., and Wahren, J., 1996, C-peptide improves autonomic nerve function in IDDM patients.Diabetologia 39687–695.

    Article  Google Scholar 

  23. Wahren, J., and Johansson, B.L., 1998, New aspects of C-peptide physiology.Horm. Metab. Res. 30A2–A5.

    Article  Google Scholar 

  24. Steiner, D.F., and Rubenstein, A.H., 1997, Proinsulin C-peptide - biological activity? [comment].Science 277531–532.

    Article  Google Scholar 

  25. Ido, Y., Vindigni, A., Chang, K., Stramm, L, ChanceR.Heath, W.F., DiMarchi, R.D., Di Cera, E., and Williamson, J.R., 1997, Prevention of vascular and neural dysfunction in diabetic rats by C-peptide.Science 277563–567

    Article  Google Scholar 

  26. Meyer, C., Hering, B.J., Grossmann, R., BrandhorstH.BrandhorstD.Gerich, J., Federlin, K., and Bretzel, R.G., 1998, Improved glucose counterregulation and autonomic symptoms after intraportal islet transplants alone in patients with type I diabetes mellitus.Transplantation 66233–240.

    Article  Google Scholar 

  27. BrandhorstD.BrandhorstH.Hering, B.J., Federlin, K., and Bretzel, R.G., 1995, Islet isolation from the pancreas of large mammals and humans: 10 years of experience.Exp. Clin. Endocrinol. Diabetes 103(suppl 2), 3–14.

    Article  Google Scholar 

  28. Hering, B.J., Bretzel, R.G., Hopt, U.T., Brandhorst, H., Brandhorst, D., Bollen, C.C., Raptis, G., Helf, F., Grossmann, R., Mellen, J., Ernst, W., Scheuermann, E.H., Schoeppe, W., Rau, W., and Federlin, K., 1994, New protocol toward prevention of early human islet allograft failure.Transplant. Proc. 26570–571.

    Google Scholar 

  29. Bretzel, R.G., Brandhorst, D., Brandhorst, H., Eckhard, M., Ernst, W., Friemann, S., Rau, W., Weimar, B., Rauber, K., Hering, B.J., and Brendel, M.D., 1999, Improved survival of intraportal pancreatic islet cell allografts in patients with type 1 diabetes mellitus by refined peritransplant management.J. Mol. Med. 77140–143.

    Article  Google Scholar 

  30. Vargas, F., Vives-Pi, M., Somoza, N., Armengol, P., Alcalde, L., Marti, M., Costa, M., Serradell, L., Dominguez, O., Fernandez-Llamazares, J., Julian, J.F., Samarti, A., and Pujol-Borrell, R., 1998, Endotoxin contamination may be responsible for the unexplained failure of human pancreatic islet transplantation.Transplantation 65722–727.

    Article  Google Scholar 

  31. Kaufman, D.B., Platt, J.L., Rabe, F.L., Dunn, D.L., Bach, F.H., and Sutherland, D.E.R., 1990, Differential roles of Mac-1+ cells and CD4+ and CD8+ T lymphocytes in primary nonfunction and classical rejection of islet allografts.J. Exp. Med. 172291–302.

    Article  Google Scholar 

  32. Bottino, R., Fernandez, L.A., Ricordi, C., Lehmann, R., Tsan, M.F., Oliver, R., and Inverardi, L., 1998, Transplantation of allogeneic islets of Langerhans in the rat liver. Effects of macrophage depletion on graft survival and microenvironment activation.Diabetes 47316–323.

    Article  Google Scholar 

  33. Menger, M.D., Vajkoczy, P., Leiderer, R., Jager, S., and Messmer, K., 1992, Influence of experimental hyperglycemia on microvascular blood perfusion of pancreatic islet isografts.J. Clin. Invest. 901361–1369.

    Article  Google Scholar 

  34. Berney, T., Molano, R.D., Cattan, P. et al., 2001, Endotoxin-mediated delayed islet graft function is associated with increased intra-islet cytokine production and islet cell apoptosis.Transplantation 71125–132.

    Article  Google Scholar 

  35. Bennet, W., SunbergB.Groth, C.G. et al., 1999, Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation?Diabetes 481907–1914.

    Article  Google Scholar 

  36. El-Ouaghlidi, A., Jahr, H., Pfeiffer, G, Hering, B.J., Brandhorst, D., Brandhorst, H., Federlin, K., and Bretzel, R.G., 1999, Cytokine mRNA expression in peripheral blood cells of immunosuppressed human islet transplant recipients.J. Mol. Med.77, 115–117.

    Article  Google Scholar 

  37. Shapiro, A.M., Gallant, H., Hao, E., Wong, J., Rajotte, R., Yatscoff, R., and Kneteman, N., 1997, Portal vein immunosuppressant levels and islet graft toxicity.Transplant. Proc. 30641.

    Article  Google Scholar 

  38. Drachenberg, C.B., Klassen, D.K., Weir, M.R., Wiland, A., Fink, J.C., Bartlett, S.T., Cangro, C.B., Blahut, S., and Papadimitriou, J.C., 1999, Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation.Transplantation 68396–402.

    Article  Google Scholar 

  39. Jaeger, C., Hering, B.J., Dyrberg, T., Federlin, K., and Bretzel, R.G., 1996, Islet cell antibodies and GAD65 antibodies in IDDM patients undergoing kidney and islet after kidney transplantation.Transplantation 62424–426.

    Article  Google Scholar 

  40. Jaeger, C., Brendel, M.D., Hering, B.J., Eckhard, M., and Bretzel, R.G., 1997, Progressive islet graft failure occurs significantly earlier in autoantibody positive than in autoantibody negative IDDM recipients of intrahepatic islet allografts.Diabetes 461907–1910.

    Article  Google Scholar 

  41. Jaeger, C., Brendel, M.D., Eckhard, M., and Bretzel, R.G., 2000, Islet autoantibodies as potential markers for disease recurrence in clinical islet transplantation. Exp. Clin. Endocrinol.Diabetes 108328–333.

    Google Scholar 

  42. Braghi, S., Bonifacio, E., Secchi, A., di Carlo, V., Pozza, G., and Bosi, E., 2000, Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes.Diabetes 49218–224.

    Article  Google Scholar 

  43. Tyden, G., Reinholt, F.P., Sundkvist, G., and Bolinder, J., 1996, Recurrence of autoimmune diabetes in recipients of cadaveric pancreatic grafts.N. Engl. J. Med. 335860–863.

    Article  Google Scholar 

  44. Halloran, P.F., Homik, J., Goes, N., Lui, S.L., Urmson, J., Ramassar, V., and Cockfield, S.M., 1997, The “injury response”: a concept linking nonspecific injury, acute rejection, and long-term transplant outcomes.Transplant. Proc. 2979–81.

    Article  Google Scholar 

  45. Roep, B.O., Stobbe, I., Duinkerken, G., van Rood, J.J., Lernmark, A., Keymeulen, B., Pipeleers, D., Claas, F.H.J., and de Vries, R.R.P., 1999, Auto-and alloimmune reactivity to human islet allografts transplanted into type-1 diabetic patients.Diabetes 48484–490.

    Article  Google Scholar 

  46. Shapiro, A.M., Lakey, J.R., Ryan, E.A., Korbutt, G.S., Toth, E., Warnock, G.L., Kneteman, N.M., and Rajotte, R.V., 2000, Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.N. Engl. J. Med. 343230–238.

    Article  Google Scholar 

  47. Ryan, E.A., Lakey, J.R.T., Rajotte, R.V. et al., 2001, Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.Diabetes 50710–719.

    Article  Google Scholar 

  48. HeringB.J.and Ricordi, C., 1999, Results, research priorities, and reasons for optimism: Islet transplantation for patients with type 1 diabetes.Graft 212–27.

    Google Scholar 

  49. Shapiro, A.M.J., Suarez-Pinzon, W.L., Power, R., and Rabinovitch, A., 2002, Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.Diabetologia 45224–230.

    Article  Google Scholar 

  50. Boehmer, H. von, and Sarukhan, A., 1999, GAD, a single autoantigen for diabetes. [comment].Science 3841135–1137.

    Article  Google Scholar 

  51. Yoon, J.W., Yoon, C.S., Lim, H.W., Huang, Q.Q., Kang, Y., Pyun, K.H., Hirasawa, K., Sherwin, R.S., and Jun, H.S., 1999, Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells.Science 2841183–1187.

    Article  Google Scholar 

  52. Yakimets, W.J., Lakey, J.R.T., Yatscoff, R.W., Katyal, D., Ao, Z., Finegood, D.T., Rajotte, R.V., and Kneteman, N.M., 1993, Prolongation of canine pancreatic islet allograft survival with combined rapamycin and cyclosporine therapy at low doses.Transplantation 561293–1298.

    Article  Google Scholar 

  53. Kneteman, N.M., Lakey, J.R., Wagner, T., and Finegood, D., 1996, The metabolic impact of rapamycin (sirolimus) in chronic canine islet graft recipients.Transplantation 611206–1210.

    Article  Google Scholar 

  54. Guo, Z., Chong, A.S., Shen, J., Foster, P., Sankary, H.N., McChesney, L., Mital, D., Jensik, S.C., Gebel, H., and Williams, J.W., 1997, In vivo effects of leflunomide on normal pancreatic islet and syngeneic islet graft function.Transplantation 63716–721.

    Article  Google Scholar 

  55. Guo, Z., Chong, A.S., Shen, J., Foster, P., Sankary, H.N., McChesney, L., Mita!, D., Jensik, S.C., and Williams, J.W., 1997, Prolongation of rat islet allograft survival by the immunosuppressive agent leflunomide.Transplantation 63711–716.

    Article  Google Scholar 

  56. Waldmann, H., 1999, Transplantation tolerance: where do we stand?Nat. Med. 111245–1248.

    Article  Google Scholar 

  57. Acholonu, I.N., and Ildstad, S.T., 1999, The role of bone marrow transplantation in tolerance: organ-specific and cellular grafts.Curr. Opin. Organ Transplant. 4189–196.

    Article  Google Scholar 

  58. Kenyon, N.S., Chatzipetron, M., Masetti, M., Ranuncoli, A., Oliveira, M., Wagner, J.L., Kirk, A.D., Harlan, D.M., Burkly, L.C., and Ricordi, C., 1999, Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD 154.Proc. Natl. Acad. Sci. USA 968132–8137.

    Article  Google Scholar 

  59. Kenyon, N.S., Fernandez, L.A., Lehmann, R., Masetti, M., Ranuncoli, A., Chatzipetron, M., Iaria, G., Han, D., Wagner, J.L., Ruiz, P., Berho, M., Inverardi, L., Alejandro, R., Mintz, D.H., Kirk, A.D., Harlan, D.M., Burkly, L.C., and Ricordi, C., 1999, Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD 154:Diabetes 481473–1481.

    Article  Google Scholar 

  60. Fändrich, F., Lin, X., Chai, G.X., Schulze, M., Ganten, D., Bader, M., Holle, J., Huang, D.-S., Parwaresch, R., Zavazava, N., and Binas, B., 2002, Preimplantation-stage stem cells induce long-term allogenic graft acceptance without supplementary host conditioning.Nat. Med. 8171–178.

    Article  Google Scholar 

  61. Chong, A.S., Yin, D., and Boussy, I.A., 2002, Transplantation tolerance: of mice and men.Graft 527–33.

    Article  Google Scholar 

  62. Kawai, T., Andrews, D., ColvinR.B.Sachs, D.H., and Cosimi, A.B., 2000, Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand.Nat. Med. 6114.

    Article  Google Scholar 

  63. Kirk, A.D., and Harlan, D.M., 2000, Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand (reply).Nat. Med. 6114.

    Article  Google Scholar 

  64. Zekorn, T., Horcher, A., Siebers, U., Federlin, K., and Bretzel, R.G., 1995, Islet transplantation in immunoseparating membranes for treatment of insulin-dependent diabetes mellitus.Exp. Clin. Endocrinol. Diabetes 103(suppl 2), 136–139.

    Article  Google Scholar 

  65. Siebers, U., Horcher, A., Bretzel, R.G., Federlin, K., and Zekorn, T., 1997, Alginate-based microcapsules for immunoprotected islet transplantation. In:Bioartificial Organs: Science Medicine and Technology(A. Prokop, D. Hunkeler, A.D. Cherrington, eds.), Annals of the New York Academy of Sciences Vol. 831, pp. 304–312.

    Article  Google Scholar 

  66. Siebers, U., Horcher, A., Brandhorst, H., Brandhorst, D., Hering, B., Federlin, K., Bretzel, R.G., and Zekom, T., 1999, Analysis of the cellular reaction towards microencapsulated xenogeneic islets after intraperitoneal transplantation.J. Mol. Med. 77215–218.

    Article  Google Scholar 

  67. de Vos, P., Hamel, A.F., and Tatarkiewicz, K., 2002, Considerations for successful transplantation of encapsulated pancreatic islets.Diabetologia 45159–173.

    Article  Google Scholar 

  68. Sun, Y., Ma, X., Zhou, D., Vacek, I., and Sun, A.M., 1996, Normalization of diabetes in spontaneously diabetic cynomolgus monkeys by xenografts of microencapsulated porcine islets without immunosuppression.J. Clin. Invest. 981417–1422.

    Article  Google Scholar 

  69. Soon-Shiong, P., Heintz, R.E., Merideth, N., Yao, Q.X., Yao, Z., Zheng, T., Murphy, M., Moloney, M.K., Schmehl, M., Harris, M., et al., 1994, Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation.Lancet 343950–951.

    Article  Google Scholar 

  70. Zekom, T.D., Horcher, A., Siebers, U., Federlin, K., and Bretzel, R.G., 1999, Synergistic effect of microencapsulation and immunoalteration on islet allograft survival in bioartificial pancreas.J. Mol. Med. 77193–198.

    Article  Google Scholar 

  71. Evans, R.W., 2001, In:Xenotransplantation(J.L. Platt, ed.), ASM Press, Washington, pp. 29–51.

    Google Scholar 

  72. Good, A.H., Cooper, D.K.C., and Malcolm, A.J. et al., 1992, Identification of carbohydrate structures which bind human anti-porcine antibodies: implications for discordant xenografting in man.Transplant. Proc. 24559–562.

    Google Scholar 

  73. Miyagawa, S., Murakami, H., Takahagi, Y., Nakai, R., Yamada, M., Murase, A., Koyota, S., Koma, M., Matsunami, K., Fukuta, D., Fujimura, T., Shigehisa, T., Okabe, M., Nagashima, H., Shirakura, R., and Taniguchi, N., 2001, Remodeling of the major pig xenoantigen by N-acetylglucosaminyltransferase III in transgenic pig.J. Biol. Chem. 2739310–39319.

    Article  Google Scholar 

  74. Wennberg, L., Wallgren, A.C., Sundberg, B., Rafael, E., Zhu, S., Tibell, A., KarlssonParra, A., Groth, C.G., Korsgren, O., 1995, Efficacy of immunosuppressive drugs in islet xenotransplantation: a study in the pig-to-rat model.Xenotransplantation 2222–229.

    Article  Google Scholar 

  75. Wennberg, L., Karlsson-Parra, A., SundbergB.Rafael, E., Liu, J., Zhu, S., Groth, C.G., and Korsgren, O., 1997, Efficacy of immunosuppressive drugs in islet xenotransplantation.Transplantation 631234–1242.

    Article  Google Scholar 

  76. Friedman, T., Smith, R.N., ColvinR.B.and Iacomini, J., 1999A critical role for human CD4+ T-cells in rejection of porcine islet cell xenografts. Diabetes 482340.

    Article  Google Scholar 

  77. Jahr, H., Brandhorst, D., Brandhorst, H., Brendel, M., Eckhardt, T., EI-Ouaghlidi, A., Hussmann, B., Lau, D., Nahidi, F., Wacker, T., Zwolinski, A., and Bretzel, R.G., 1998, Abstossungsreaktionen bei der tierexperimentellen xenogenen Transplantation von isolierten Langerhansschen Inseln des Schweins.Zentralbl. Chir. 123823–829.

    Google Scholar 

  78. Lau, D., Hering, B.J., EI-Ouaghlidi, A., Jahr, H., Brandhorst, H., Brandhorst, D., Vietzke, R., Federlin, K., and Bretzel, R.G., 1999, Isokinetic gradient centrifugation prolongs survival of pig islets xenografted intomice. J. Mol. Med.77, 175–177.

    Article  Google Scholar 

  79. Lai, L., Kolber-Simonds, D., Kwang-Wook, P., Cheong, H.-T., Greenstein, J.L., Im, G.- S., Samuel, M., Bonk, A., Rieke, A., Day, B.N., Murphy, C.N., Carter, D.B., Hawley, R.J., and Prather, R.S., 2002, Production of A-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning.Science295, 1089–1092.

    Article  Google Scholar 

  80. Brown, J., Danilovs, J.A., Clark, W.R., and Mullen, Y.S., 1984, Fetal pancreas as a donor organ.World J. Surg. 8152–157.

    Article  Google Scholar 

  81. Korsgren,0. 1991, Xenotransplantation of fetal porcine islet-like cell clusters in diabetes mellitus: an experimental and clinical study.Acta Univ. Upsal. 2951–40.

    Google Scholar 

  82. Korsgren, 0., Sandler, S., Landström, A., Jansson, L., Andersson, A., 1988, Large-scale production of fetal porcine pancreatic islet-like cell clusters. An experimental tool for studies of islet cell differentiation and xenotransplantation.Transplantation 45509–514.

    Article  Google Scholar 

  83. Korsgren, O., Jansson, L., Eizirik, D., and Andersson, A., 1991, Functional and morphological differentiation of fetal porcine islet-like cell clusters after transplantation into nude mice.Diabetologia 34379–386.

    Article  Google Scholar 

  84. Liu, X., Federlin, K.F., Bretzel, R.G., Hering, B.J., and Brendel, M.D., 1991, Persistent reversal of diabetes by transplantation of fetal pig proislets into nude mice.Diabetes 40858–866.

    Article  Google Scholar 

  85. Liu, X., Brendel, M.D., Hering, B.J., Bretzel, R.G., and Federlin, K., 1992, Comparison of the potency of fetal pig pancreatic proislets and fragments to reverse diabetes.Transplant. Proc. 24987.

    Google Scholar 

  86. Liu, X., Brendel, M.D., Brandhorst, H., Klitscher, D., Hering, B.J., Federlin, K.F., and Bretzel, R.G., 1993, Successful cryopreservation of fetal porcine proislets.Cryobiology 30262–271.

    Article  Google Scholar 

  87. Liu, X., Brendel, M.D., Brandhorst, D., Brandhorst, H., Hering, B.J., Federlin, K., and Bretzel, R.G., 1994, Reversal of diabetes in nude mice by transplantation of cryopreserved fetal porcine proislets.Transplant. Proc. 26707–708.

    Google Scholar 

  88. Bretzel, R.G., Liu, X., Hering, B.J., Brendel, M., and Federlin, K., 1995, Cryopreservation transplantation and susceptibility to diabetogenic agents of fetal porcine proislets.Xenotransplantation 2133–138.

    Article  Google Scholar 

  89. Soderlund, J., Wennberg, L., Castanos-Velez, E. et al., 1999, Fetal porcine islet-like cell clusters transplanted to cynomolgus monkeys: an immunohistochemical study.Transplantation 67784.

    Article  Google Scholar 

  90. Groth, C.G., Andersson, A., Björken, C., Gunnarsson, R., Hellerstrbm, C., Lundgren, G., Petersson, B., Swenne, I., and Östman, J., 1980, Transplantation of fetal pancreatic microfragments via the portal vein to a diabetic patients.Diabetes 2980–83.

    Google Scholar 

  91. Groth, C.G., Korsgren, O., Tibell, A. et al., 1994, Transplantation of porcine fetal pancreas to diabetic patients.Lancet 3441402–1404.

    Article  Google Scholar 

  92. Bach, F.H., Fishman, J.A., Daniels, N. et al., 1988, Uncertainty in xenotransplantation: individual benefit versus collective risk.Nat. Med. 4141–144.

    Article  Google Scholar 

  93. Patience, C., Takeuchi, Y., and Weiss, R.A., 1997, Infection of human cells by an endogenous retrovirus of pigs.Nat. Med. 3275–276.

    Article  Google Scholar 

  94. Martin, U., Kiessig, V., Blusch, J.H., Haverich, A., von der Helm, K., Herden, T., and Steinhoff, G., 1998, Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells.Lancet 352666–667.

    Article  Google Scholar 

  95. Van der Laan, L.J., Lockey, C., Griffeth, B.C. et al., 2000, Infection by porcine endogenous retroviruses after islet xenotransplantation in SCID mice.Nature 40790–94.

    Article  Google Scholar 

  96. Deng, Y.M., Tuch, B.E., and Rawlinson, W.D., 2000, Transmission of porcine endogenous retroviruses in severe combined immunodeficient mice xenotransplanted with fetal porcine pancreatic cells.Transplantation 701010–1016.

    Article  Google Scholar 

  97. Heneine, W., Tibell, A., Switzer, W.M. et al., 1998, No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts.Lancet 352695–699.

    Article  Google Scholar 

  98. Paradis, K., Langford, G., Long, Z. et al., 1999, Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue.Science 2851236–1241.

    Article  Google Scholar 

  99. SoriaB.Skoudy, A., and Martin, F., 2001, From stem cells to beta cells: new strategies in cell therapy of diabetes mellitus.Diabetologia 44.407–415.

    Article  Google Scholar 

  100. Edlund, H., 1958, Transcribing the pancreas.Diabetes 471817–1823.

    Article  Google Scholar 

  101. Stoffers, D.A., Zinkin, N.T., Stanojevic, V., Clarke, W.L., and Habener, J.F., 1997, Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence.Nat. Genet. 15106–110.

    Article  Google Scholar 

  102. Apelqvist, A., Li, H., Sommer, L., Beatus, P., Anderson, D.J., Honjo, T.deAngelis, M., Lendahl, U., and Edlund, H., 1999, Notch signalling controls pancreatic cell differentiation.Nature 400877–881.

    Article  Google Scholar 

  103. Gradwohl, G., Dierich, A., Le Meur, M., and Guillemot, F., 2000, Neurogenin 3 is required for the development of the four endocrine cell lineages of the pancreas.Proc. Natl. Acad. Sci. USA 971607–1611.

    Article  Google Scholar 

  104. Sosa-Pineda, B., Chowdhury, K., Torres, M., Oliver, G., and Gruss, P., 1997, The Pax 4 gene is essential for differentiation of insulin-producing beta cells in the mammalian pancreas.Nature 386399–402.

    Article  Google Scholar 

  105. Soria, B., Roche, E., Berna, G., Leon-Quinto, T., Reig, J.A., and Martin, F., 2000, Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice.Diabetes 49157–162.

    Article  Google Scholar 

  106. Lumelsky, N., Blondel, O., Laeng, P., Velasco, I., Ravin, R., and McKay, R., 2001, Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets.Science 2921389–1394.

    Article  Google Scholar 

  107. Assady, S., Maor, G., Amit, M., Itskovitz-Eldor, J., Skorecki, K.L., and Tzuckerman, M., 2001, Insulin production by human embryonic stem cells.Diabetes 501691–1697.

    Article  Google Scholar 

  108. Zulewski, H., Abraham, E.J., Gerlach, M.J., Daniel, P.B., Moritz, W., Muller, B., Vallejo, M., Thomas, M.K., and Habener, J.F., 2001, Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes.Diabetes 50521–533.

    Article  Google Scholar 

  109. Ramiya, V.K., Maraist, M., Arfors, K.E., Schatz, D.A., Peck, A.B., and Cornelius, J.G., 2000, Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells.Nat. Med. 6278–282.

    Article  Google Scholar 

  110. Bonner-Weir, S., Taneja, M., Weir, G.C., Tatarkiewicz, K., Song, K.H., Sharma, A., and O’Neill, J.J., 2000, In vitro cultivation of human islets from expanded ductal tissue.Proc. Natl. Acad. Sci. USA 977999–8004.

    Article  Google Scholar 

  111. Soria, B., Andreu, E., Berna, G., Fuentes, E., Gil, A., Leon-Quinto, T., Martin, F., Montanya, E., Nadal, A., Reig, J.A., Ripoll, C., Roche, E., Sanchez-Andres, and J.V., Segura, J., 2000, Engineering pancreatic islets.Eur. J. Physiol. 4401–18.

    Google Scholar 

  112. Cheung, A.T., Dayanandan, B., Lewis, J.T., Korbutt, G.S., Rajotte, R.V., Bryer-Ash, M., Boylan, M.O., Wolfe, M.M., and Kieffer, T.J., 2000, Glucose-dependent insulin release from genetically engineered K cells.Science 2901959–1962.

    Article  Google Scholar 

  113. Lee, H.C., Kim, S.J., Kim, K.S., Shin, H.C., and Yoon, J.W., 2000, Remission in models of type I diabetes by gene therapy using a single-chain insulin analogue.Nature 408483–488.

    Article  Google Scholar 

  114. Shaw, J.A.M., Delday, M.I., Hart, A.W., and Docherty, K., 2002, Secretion of bioactive human insulin following plasmid-mediated gene transfer to non-neuroendocrine cell lines, primary cultures and rat skeletal muscle in vivo.J. Endocrinol. 172653–672.

    Article  Google Scholar 

  115. Riu, E., Mas, A., Ferre, T., Pujol, A., Gros, L., Otaegui, P., Montoliu, L., and Bosch, F., 2002, Counteraction of type 1 diabetic alterations by engineering skeletal muscle to produce insulin: insights from transgenic mice.Diabetes 51704–711.

    Article  Google Scholar 

  116. Ferber, S., Halkin, A., Cohen, H., Ber, I., Einav, Y., Goldberg, I., Barshack, I., Seijfers, R., Kopolovic, J., Kaiser, N., and Karasik, A., 2000, Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocininduced hyperglycemia.Nat. Med. 6568–572.

    Article  Google Scholar 

  117. Kahn, A., 2000, Converting hepatocytes to E-cells - a new approach for diabetes?Nat. Med. 6505–506.

    Article  Google Scholar 

  118. Weir, G.C., and Bonner-Weir, S., 1997, Scientific and political impediment to successful islet transplantation.Diabetes 461247–1256.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Third Medical Department and Policlinic, University Hospital Giessen, Rodthohl 6, D-35392, Giessen, Germany

    Reinhard G. Bretzel

Authors
  1. Reinhard G. Bretzel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Science Faculty and Biotechnology Institute, Ankara University, Ankara, Turkey

    Y. Murat Elçin

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Bretzel, R.G. (2003). Pancreatic Islet and Stem Cell Transplantation in Diabetes Mellitus: Results and Perspectives. In: Elçin, Y.M. (eds) Tissue Engineering, Stem Cells, and Gene Therapies. Advances in Experimental Medicine and Biology, vol 534. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0063-6_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0063-6_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4907-5

  • Online ISBN: 978-1-4615-0063-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation